Opexa Pharmaceuticals, Inc. to Participate in Panel Discussion on Personalized Medicine for Multiple Sclerosis

Published: Apr 01, 2010

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the company will participate in a panel discussion on Personalized Medicine for the Treatment of Multiple Sclerosis on April 7, 2010.

Back to news